DBV Technologies DBVT
NASDAQ DBVT
$11.76 +0.21 (+1.82%)
At close: Sep 30, 2026 · 4:00 PM EDT

DBV Technologies (DBVT) Change in Receivables (2020 - 2021)

Updated

DBV Technologies (DBVT) reported Change in Receivables of $24,000 for Q4 2021, down 75.0% from $96,000 a year earlier.

Analysis

DBV Technologies (DBVT) Change in Receivables (2020 - 2021) Analysis & Trends

For FY2021, DBV Technologies posted Change in Receivables of -$2.15 million.

  • By year, Change in Receivables came in at $2.07 million in FY2020, -$34,000 in FY2019, $1.45 million in FY2018 and $3,388 in FY2017.
  • Five-year quarterly Change in Receivables spans a low of -$2.1 million in Q1 2021 and a high of $1.98 million in Q3 2020.
  • Per Business Quant data, the three quarters before Q4 2021 came in at $1,000 (Q3 2021), -$74,000 (Q2 2021) and -$2.1 million (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 DBV Technologies 5.10 Bn 4.43 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 24,000.00
Sep 30, 2021 1,000.00
Jun 30, 2021 -74,000.00
Mar 31, 2021 -2.10 Mn
Dec 31, 2020 96,000.00
Sep 30, 2020 1.98 Mn
API Access

DBV Technologies Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=DBVT&period=max&api_key=YOUR_API_KEY